Header Logo

Connection

Charles Feldman to Bacterial Proteins

This is a "connection" page, showing publications Charles Feldman has written about Bacterial Proteins.
Connection Strength

2,043
  1. Exposure of a 23F serotype strain of Streptococcus pneumoniae to cigarette smoke condensate is associated with selective upregulation of genes encoding the two-component regulatory system 11 (TCS11). Biomed Res Int. 2014; 2014:976347.
    View in: PubMed
    Score: 0,432
  2. Pneumolysin in the immunopathogenesis and treatment of pneumococcal disease. Expert Rev Anti Infect Ther. 2003 Aug; 1(2):231-9.
    View in: PubMed
    Score: 0,204
  3. Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
    View in: PubMed
    Score: 0,162
  4. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci. 2018 Apr 11; 19(4).
    View in: PubMed
    Score: 0,141
  5. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017 12; 75(6):473-485.
    View in: PubMed
    Score: 0,136
  6. Pneumolysin as a potential therapeutic target in severe pneumococcal disease. J Infect. 2017 06; 74(6):527-544.
    View in: PubMed
    Score: 0,131
  7. A pivotal role for pneumolysin in the immunopathogenesis, treatment and prevention of pneumococcal disease. S Afr Med J. 2007 Nov; 97(11 Pt 3):1141-5.
    View in: PubMed
    Score: 0,068
  8. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother. 2007 Nov; 60(5):1155-8.
    View in: PubMed
    Score: 0,068
  9. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother. 2007 Feb; 59(2):224-9.
    View in: PubMed
    Score: 0,065
  10. Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium. Int J Infect Dis. 2007 Jan; 11(1):11-5.
    View in: PubMed
    Score: 0,061
  11. Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid. Clin Exp Immunol. 2005 May; 140(2):274-81.
    View in: PubMed
    Score: 0,057
  12. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz). 2005 May-Jun; 53(3):189-98.
    View in: PubMed
    Score: 0,057
  13. Pro-inflammatory interactions of streptolysin O toxin with human neutrophils in vitro. J Immunotoxicol. 2024 Dec; 21(1):2345152.
    View in: PubMed
    Score: 0,054
  14. The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. Respir Med. 2002 Aug; 96(8):580-5.
    View in: PubMed
    Score: 0,047
  15. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis. 2002 Jun; 15(3):235-9.
    View in: PubMed
    Score: 0,047
  16. Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa. Lett Appl Microbiol. 2020 Jan; 70(1):21-28.
    View in: PubMed
    Score: 0,039
  17. Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro. J Infect. 2017 06; 74(6):599-608.
    View in: PubMed
    Score: 0,033
  18. Pneumolysin Mediates Platelet Activation In Vitro. Lung. 2016 08; 194(4):589-93.
    View in: PubMed
    Score: 0,031
  19. Pneumolysin activates neutrophil extracellular trap formation. Clin Exp Immunol. 2016 06; 184(3):358-67.
    View in: PubMed
    Score: 0,030
  20. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J. 2013 Feb; 41(2):392-5.
    View in: PubMed
    Score: 0,024
  21. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol. 1991 Nov; 5(5):416-23.
    View in: PubMed
    Score: 0,023
  22. Characterization of the interactions of the pneumolysoid, ?6 PLY, with human neutrophils in vitro. Vaccine. 2011 Nov 08; 29(48):8780-2.
    View in: PubMed
    Score: 0,022
  23. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathog. 1990 Oct; 9(4):275-84.
    View in: PubMed
    Score: 0,021
  24. Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Eur Respir J. 2009 Nov; 34(5):1167-70.
    View in: PubMed
    Score: 0,020
  25. Pneumolysin potentiates oxidative inactivation of alpha-1-proteinase inhibitor by activated human neutrophils. Respir Med. 2004 Sep; 98(9):865-71.
    View in: PubMed
    Score: 0,014
  26. Docosahexaenoic acid and eicosapentaenoic acid antagonize the proinflammatory interactions of pneumolysin with human neutrophils. Infect Immun. 2004 Jul; 72(7):4327-9.
    View in: PubMed
    Score: 0,014
  27. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis. 2002 Aug 15; 186(4):562-5.
    View in: PubMed
    Score: 0,012
  28. Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun. 2001 May; 69(5):3494-6.
    View in: PubMed
    Score: 0,011
  29. Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis. 2001 Feb 15; 183(4):604-11.
    View in: PubMed
    Score: 0,011
  30. Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo. Infect Immun. 1992 Nov; 60(11):4969-72.
    View in: PubMed
    Score: 0,006
  31. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989 Jul; 57(7):2006-13.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.